Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Pulmatrix, Inc.    PULM

PULMATRIX, INC.

(PULM)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news

PULMATRIX, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

share with twitter share with LinkedIn share with facebook
share via e-mail
11/19/2019 | 07:09am EST

Item 7.01. Regulation FD Disclosure.

Pulmatrix, Inc. (the "Company") intends, from time to time, to present and/or distribute to the investment community and utilize at various industry and other conferences a slide presentation, which is attached hereto as Exhibit 99.1. The Company undertakes no obligation to update, supplement or amend the materials attached hereto as Exhibit 99.1.

In accordance with General Instruction B.2 of Form 8-K, the information in this Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by reference in such a filing. Furthermore, the furnishing of information under Item 7.01 of this Current Report on Form 8-K is not intended to constitute a determination by the Company that the information contained herein, including the exhibits hereto, is material or that the dissemination of such information is required by Regulation FD.

Item 9.01 Financial Statements and Exhibits.



(d) Exhibits



Exhibit
Number       Description

99.1           Investor Presentation, dated November 2019 (furnished herewith
             pursuant to Item 7.01).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on PULMATRIX, INC.
01/30PULMATRIX, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
01/30PULMATRIX : Receives Fast Track Designation for Pulmazole for the Treatment of A..
PR
01/16PULMATRIX, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
01/16PULMATRIX : Regains Compliance with Nasdaq Minimum Bid Price Requirement
PR
01/13PULMATRIX, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (f..
AQ
01/06PULMATRIX : Announces Research Collaboration with Nocion Therapeutics to Explore..
PR
01/02PULMATRIX, INC. : Entry into a Material Definitive Agreement, Other Events, Fina..
AQ
01/02PULMATRIX : Announces Kinase Inhibitor Licensing Agreement with Lung Cancer Init..
PR
2019PULMATRIX, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (f..
AQ
2019PULMATRIX, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
More news